Merritt Island Medical Research

What Merritt Island Medical Research does

Merritt Island Medical Research, now operating as Merritt Island Clinical Research, is a Florida-based clinical research site specializing in memory testing, consultation, and clinical trials for neurodegenerative disorders — with a particular focus on Alzheimer's disease. The site was founded in 2015 and operates as a location within the Flourish Research multi-state clinical research network, which spans 11+ U.S. states and is headquartered in Apex, North Carolina. The site recruits patients through a community-led go-to-market approach, employing physician referrals, community impact programs, social media, and a website-based study-search and scheduling portal to drive enrollment into active studies.

The site's core product is clinical trial conduct services delivered to pharmaceutical companies and research sponsors, generating revenue through study contracts that cover patient recruitment, study execution, and data collection. Beyond its Alzheimer's specialization, the site offers diagnostic testing services (ECGs, lab work, radiological tests, medical exams, genetic testing) at no cost to participants, in-patient and overnight research capabilities for continuous-monitoring studies, and demographic-specific trial programs covering men's, women's, pediatric, and senior populations. Participants receive monetary compensation for time and travel, and all services are provided free of charge to volunteers. The underlying technology is operational rather than proprietary — clinical research facility infrastructure, a website study portal, and standard digital scheduling — with no disclosed AI/ML components, patents, or proprietary software.

The business model is a professional services, sponsor-funded revenue model: pharmaceutical companies and research sponsors pay for clinical trial conduct, while patients serve as the recruited participants (not the paying customers). Customer segments are therefore two-sided — clinical trial volunteers (the recruited supply) and pharma/biotech sponsors (the monetized demand). The site positions domain specialization in Alzheimer's and neurodegenerative disorders, combined with membership in the Flourish Research network, as its primary competitive differentiators.

Name

Merritt Island Medical Research

Legal name

Flourish Research

Website

https://mimresearch.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Merritt Island Medical Research is a Florida-based clinical research site specializing in Alzheimer's disease and neurodegenerative disorder trials, operating as a location within the Flourish Research multi-state clinical research network. The site recruits patient volunteers and delivers sponsor-funded clinical trial conduct services to pharmaceutical and biotech clients.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Medical and Diagnostic Laboratories (62151), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industry

Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

• Clinical trial services
• Alzheimer's research
• Neurodegenerative studies
• Diagnostic testing
• Clinical research site

Headquarters

HQ city

Merritt Island

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Trial Conduct Services: Conducts clinical trials on behalf of pharmaceutical companies and research sponsors. Revenue is generated through study contracts, where sponsors pay for research services including patient recruitment, study execution, and data collection.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Merritt Island Medical Research operates a clinical research site that conducts Phase I–IV clinical trials, with a primary focus on neurodegenerative disorders such as Alzheimer's disease. The site offers diagnostic testing services and in-patient/overnight study capabilities for trial participants at no cost, while serving as a contracted research site for pharmaceutical sponsors and clinical research organizations.

Product overview

Merritt Island Medical Research, now operating as Merritt Island Clinical Research under Flourish Research, is a clinical research site offering a unified platform of clinical trial services. The organization specializes in neurodegenerative disorders research, particularly Alzheimer's disease, and provides diagnostic testing, in-patient services, and specialized trials for various demographics including men, women, pediatric, and senior populations. The product portfolio centers on clinical trial participation, diagnostic testing services, and overnight/in-patient research capabilities, all offered at no cost to participants with compensation for time and travel.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trials for Neurodegenerative Disorders

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Medpace: Mid-to-large CRO with therapeutic expertise across neuroscience, comparable as a broad incumbent competing for the same Alzheimer's and neurodegenerative trial sponsorships.
• IQVIA: Largest global CRO with site management operations including neuroscience, comparable as a buyer/competitor of site-level trial services and an indirect counterparty for sponsor contracts.
• Syneos Health: Large biopharmaceutical solutions organization with site network and CNS franchise, comparable as a broad incumbent providing end-to-end clinical development including site management.
• ICON plc: Global CRO with significant neuroscience and Alzheimer's trial experience, comparable as a broad incumbent offering site services, feasibility, and patient recruitment at scale.
• Fortrea (formerly Labcorp Drug Development): Large CRO offering clinical trial services across therapeutic areas including CNS, comparable as a broad incumbent that competes for the same sponsor relationships driving site revenue.

Direct peers

• Benchmark Research: Multi-site clinical research organization with therapeutic areas overlapping Merritt Island's portfolio, comparable in operating model as a Phase I–IV trial site serving pharmaceutical sponsors.
• Accel Research Sites: Multi-therapeutic clinical research site network operating across Florida with similar Phase I–III trial execution capabilities, directly comparable in site-model, geographic overlap, and sponsor-facing service mix.
• Compass Research: Florida-based clinical trial site network with similar therapeutic breadth including CNS and neurodegenerative studies, comparable patient-recruitment-driven GTM and sponsor contract model.
• CNS Healthcare: Specialty clinical research organization focused on central nervous system and neurodegenerative disorder trials, highly comparable in therapeutic focus (Alzheimer's/Parkinson's) and site-based patient recruitment.
• WCCT Global (Worldwide Clinical Trials Early Phase): Clinical trial site organization with in-patient and overnight study capabilities, directly comparable in offering extended-stay research services and a diversified therapeutic trial portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/FlourishMerrittIsland
• LinkedInlinkedin.com/company/flourishresearch
• Instagraminstagram.com/flourishresearchme

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Merritt Island Medical Research